1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VIRIDIAN THERAPEUTICS INC
Viridian Therapeutics Inc XNAS: VRDN

Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-00...

Read More
18.44 -0.12 (-0.65%)
32.21% Fall from 52W High
485.4K
XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
6.2 / 100
Momentum Score
Technically Moderately Bullish
66.2 / 100
Analyst Price Target
38
1Yr Price target upside is 108%
15 analysts

13

S

7

W

5

O

0

T

SWOT Analysis

Viridian Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..